Full integration of digital breast tomosynthesis reduces false positive rates, study shows

(American Roentgen Ray Society) Rates of false positive breast cancer screening exams fell significantly after complete integration of diagnostic digital breast tomosynthesis (DBT), potentially leading to higher quality, lower costs, and fewer unnecessary biopsies, according to a study to be presented at the ARRS 2018 Annual Meeting, set for April 22-27 in Washington, DC.